Clinical trial · Interventional
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer: Symptoms, Risc Factors, and Prevention
NCT00957606CI-TRIAL-00004673OsteoporosisunknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is * to determine the rate of osteoporosis among patients with advanced prostate cancer. * to propose an algorithm for early detection of patients with advanced prostate cancer who are at risk of developing osteoporosis.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Androgen Deprivation Therapy | — | UNRESOLVED | — |
| Osteoporosis | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood sampling, DXA-scan, bone scintigraphy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Osteoporosis, either T-score < -2,5 or osteoporosis fracture
- timeFrame
- 2½ years
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Prostate cancer * Initiation of androgen deprivation therapy * Oral and written informed consent Exclusion Criteria: * They withdraw their consent * Treatment for osteoporosis within the last year * Other malignancy * Other bone disease, bedbound, use of steroid
References
Publications (0)
Data not yet available
No reference posted for this study.